Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 17/20 | 0.78 |
| ▸ | HDAC4 | P56524 | 15/20 | 0.78 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.78 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.78 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.78 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.78 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.78 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.78 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.78 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.78 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9754027 | 0.87 | HDAC1 (0.84) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| SCHEMBL13916999 | 0.86 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| SCHEMBL4741062 | 0.86 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| SCHEMBL29740175 | 0.86 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| SCHEMBL24418494 | 0.81 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| SCHEMBL21863696 | 0.81 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| SCHEMBL29354176 | 0.81 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| Trapoxin B SCHEMBL12055209 | 0.76 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| Trapoxin B SCHEMBL18912063 | 0.76 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 | |
| Trapoxin B SCHEMBL14285967 | 0.76 | HDAC1 (1.00) | HDAC1HDAC4HDAC6HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9540317-B2 | Class- and isoform-specific HDAC inhibitors and uses thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-01-10 | — | — | US | disclosed |